Format
Sort by
Items per page

Send to

Choose Destination

Best matches for vaccine:

Influenza vaccines: from whole virus preparations to recombinant protein technology. Huber VC et al. Expert Rev Vaccines. (2014)

Current status and future prospects of yellow fever vaccines. Beck AS et al. Expert Rev Vaccines. (2015)

Recent approaches in vaccine development against Streptococcus pneumoniae. Tarahomjoo S et al. J Mol Microbiol Biotechnol. (2014)

Search results

Items: 1 to 20 of 302787

1.

Facilitators And Barriers For Use Of Rotavirus Vaccine Amongst Various Stakeholders And Its Implications For Indian Context - A Systematic Review.

Apte A, Roy S, Bavdekar A, Juvekar S, Hirve S.

Hum Vaccin Immunother. 2018 Jun 18:1-23. doi: 10.1080/21645515.2018.1489190. [Epub ahead of print]

PMID:
29913110
2.

Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant.

Neto LMM, Zufelato N, de Sousa-Júnior AA, Trentini MM, da Costa AC, Bakuzis AF, Kipnis A, JunqueiraKipnis AP.

Hum Vaccin Immunother. 2018 Jun 18:1-56. doi: 10.1080/21645515.2018.1489192. [Epub ahead of print]

PMID:
29913109
3.

Generalized ROC methods for immunogenicity data analysis of vaccine phase I studies in a seropositive population.

Yu L, Esser MT, Falloon J, Villafana T, Yang H.

Hum Vaccin Immunother. 2018 Jun 18:1-29. doi: 10.1080/21645515.2018.1489191. [Epub ahead of print]

PMID:
29913105
4.

Immunization rates of pneumococcal, influenza and tetanus vaccines and knowledge and attitudes of adult patients who receive inpatient treatment at hospital: Point prevalence study.

Ahmad hamİdİ A, Gelmez taŞ B, GÜndÜz A, Nur Çelebİ S, Esen ES, Toprak D, DÖkmetaŞ İ.

Hum Vaccin Immunother. 2018 Jun 18:1-22. doi: 10.1080/21645515.2018.1489187. [Epub ahead of print]

PMID:
29913102
5.

Non-viral pathogens: Identification, relevance, and prevention for xenotransplantation.

Tönjes RR.

Xenotransplantation. 2018 May;25(3):e12413. doi: 10.1111/xen.12413.

PMID:
29913046
6.

A recombinant herpesviral vector containing a near-full-length SIVmac239 genome produces SIV particles and elicits immune responses to all nine SIV gene products.

Shin YC, Bischof GF, Lauer WA, Gonzalez-Nieto L, Rakasz EG, Hendricks GM, Watkins DI, Martins MA, Desrosiers RC.

PLoS Pathog. 2018 Jun 18;14(6):e1007143. doi: 10.1371/journal.ppat.1007143. [Epub ahead of print]

PMID:
29912986
7.

RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection.

Ates LS, Sayes F, Frigui W, Ummels R, Damen MPM, Bottai D, Behr MA, van Heijst JWJ, Bitter W, Majlessi L, Brosch R.

PLoS Pathog. 2018 Jun 18;14(6):e1007139. doi: 10.1371/journal.ppat.1007139. [Epub ahead of print]

PMID:
29912964
8.

Acellular pertussis vaccines effectiveness over time: A systematic review, meta-analysis and modeling study.

Chit A, Zivaripiran H, Shin T, Lee JKH, Tomovici A, Macina D, Johnson DR, Decker MD, Wu J.

PLoS One. 2018 Jun 18;13(6):e0197970. doi: 10.1371/journal.pone.0197970. eCollection 2018.

PMID:
29912887
9.

Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong.

Cheung T, Lau JTF, Wang JZ, Mo PKH, Ho YS.

PLoS One. 2018 Jun 18;13(6):e0198615. doi: 10.1371/journal.pone.0198615. eCollection 2018.

PMID:
29912883
10.

The protective capacity of high payload FMDV A22 IRQ vaccine in sheep against direct-contact challenge with a heterologous, contemporary FMDV A strain from South East Asia.

Horsington J, Nfon C, Bittner H, Durr PA, Singanallur N, Alexandersen S, Vosloo W.

PLoS One. 2018 Jun 18;13(6):e0195302. doi: 10.1371/journal.pone.0195302. eCollection 2018.

PMID:
29912868
11.

Antibody Persistence up to 3 Years after Primary Immunization with Inactivated Japanese Encephalitis Vaccine IXIARO® in Philippine Children and Effect of a Booster Dose.

Kadlecek V, Borja-Tabora CF, Eder-Lingelbach S, Gatchalian S, Kiermayr S, Sablan B Jr, Kundi M, Taucher C, Dubischar KL.

Pediatr Infect Dis J. 2018 Jun 15. doi: 10.1097/INF.0000000000002124. [Epub ahead of print]

PMID:
29912844
12.

Microevolution and Patterns of Transmission of Shigella sonnei within Cyclic Outbreaks Shigellosis, Israel.

Behar A, Baker KS, Bassal R, Ezernitchi A, Valinsky L, Thomson NR, Cohen D.

Emerg Infect Dis. 2018 Jul;24(7):1335-1339. doi: 10.3201/eid2407.171313.

PMID:
29912703
13.

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.

Silva-Costa C, Brito MJ, Pinho MD, Friães A, Aguiar SI, Ramirez M, Melo-Cristino J; Portuguese Group for the Study of Streptococcal Infections; Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society.

Emerg Infect Dis. 2018 Jul;24(7):1307-1314. doi: 10.3201/eid2407.180029.

PMID:
29912700
14.

Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada.

Mahmud SM, Bozat-Emre S, Mostaço-Guidolin LC, Marrie RA.

Emerg Infect Dis. 2018 Jul;24(7):1267-1274. doi: 10.3201/eid2407.161783.

PMID:
29912696
15.

Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009-June 20151.

Regev-Yochay G, Reisenberg K, Katzir M, Wiener-Well Y, Rahav G, Strahilevitz J, Istomin V, Tsyba E, Peretz A, Khakshoor S, Dagan R; Israeli Adult Invasive Pneumococcal Disease Group.

Emerg Infect Dis. 2018 Jul;24(7):1275-1284. doi: 10.3201/eid2407.170721.

PMID:
29912694
16.

Progress and Remaining Gaps in Estimating the Global Disease Burden of Influenza.

Bresee J, Fitzner J, Campbell H, Cohen C, Cozza V, Jara J, Krishnan A, Lee V; WHO Working Group on the Burden of Influenza Disease.

Emerg Infect Dis. 2018 Jul;24(7):1173-1177. doi: 10.3201/eid2407.171270.

PMID:
29912681
17.

Integrated Serologic Surveillance of Population Immunity and Disease Transmission.

Arnold BF, Scobie HM, Priest JW, Lammie PJ.

Emerg Infect Dis. 2018 Jul;24(7):1188-1194. doi: 10.3201/eid2407.171928.

PMID:
29912680
18.

Functional Characterization of Plasmodium falciparum Surface Related Antigen (PfSRA) as a Potential Blood-Stage Vaccine Target.

Amlabu E, Mensah-Brown H, Nyarko PB, Akuh OA, Opoku G, Ilani P, Oyagbenro R, Asiedu K, Aniweh Y, Awandare GA.

J Infect Dis. 2018 Apr 18. doi: 10.1093/infdis/jiy222. [Epub ahead of print]

PMID:
29912472
19.

Induction of Cross-Clade Antibody and T-Cell Responses by an MVA-Based Influenza H5N1 Vaccine in a Randomized Phase I/IIa Clinical Trial.

de Vries RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, van Trierum SE, Pronk MR, Lamers MM, Richard M, Nieuwenhuijse DF, Koopmans MPG, Kreijtz JHCM, Fouchier RAM, Osterhaus ADME, Sutter G, Rimmelzwaan GF.

J Infect Dis. 2018 Apr 18. doi: 10.1093/infdis/jiy214. [Epub ahead of print]

PMID:
29912453
20.

[Parotiditis in Chile: clinical and molecular characterization of two cases in a highly vaccinated population].

Le-Corre N, Barría S, López T, Martínez-Valdebenito C, Contreras AM, Ferrés M.

Rev Chilena Infectol. 2018 Apr;35(2):198-203. doi: 10.4067/s0716-10182018000200198. Spanish.

PMID:
29912260

Supplemental Content

Loading ...
Support Center